STALEVO Safety Questions, STALEVO Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about STALEVO. Our extensive database of STALEVO adverse events and STALEVO warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about STALEVO

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




STALEVO Safety Reports

Total STALEVO reports: 198.
STALEVO FDA safety alerts: No.
Reported deaths: 16    Reported hospitalizations: 91.
Take STALEVO Side Effects Survey or Share Your STALEVO Story. Read More Here.

Showing 1-75 of 198 Next >

Consumer or non-health professional from UNITED STATES reported STALEVO problem on June 06, 2006. Female patient, 73 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: feeling drunk. STALEVO dosage: 250 MG, 5 IN 1 D, ORAL. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from BRAZIL on July 19, 2006. Male patient, 90 years of age, weighting 220.5 lb, was diagnosed with parkinson's disease, hypertension and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: agitation, anaemia, anorexia, aspiration, asthenia, laryngospasm, pneumonia aspiration, sleep disorder. STALEVO dosage: 200 MG, BID. During the same period patient was treated with ENALAPRIL MALEATE, CAPTOPRIL, CILOSTAZOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STALEVO problem on Mar 24, 2006. Female patient, 81 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: back pain, headache, myalgia. STALEVO dosage: unknown. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2006. Female patient, 50 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: condition aggravated, gastrooesophageal reflux disease. STALEVO dosage: 750 MG, 5 IN 1 D, ORAL. During the same period patient was treated with SINEMET. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STALEVO problem on Mar 15, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, dizziness, pain. STALEVO dosage: 300 MG, 3 IN 1 D, ORAL : 150 MG, 3 IN 1 D, ORAL. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2006. Male patient was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: tremor. STALEVO dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STALEVO problem on Mar 12, 2006. Male patient, 80 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: burning sensation, dysuria, gait disturbance, polyuria, urine colour abnormal. STALEVO dosage: 300 MG, 3 IN 1 D, ORAL. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Male patient, 63 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: nasopharyngitis. STALEVO dosage: 150 MG, 3 IN 1 D, ORAL. During the same period patient was treated with LACTIC ACID BACTERIA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STALEVO problem on Mar 24, 2006. Female patient, 80 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: joint stiffness, masked facies, staring, tremor. STALEVO dosage: 200 MG, 2 IN 1 D, ORAL. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2006. Female patient was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: dysstasia, tremor. STALEVO dosage: 100 MG Q3H, ORAL. During the same period patient was treated with SINEMET. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STALEVO problem on Apr 10, 2006. Male patient was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: aggression, paranoia. STALEVO dosage: unknown. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2006. Female patient, 85 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: condition aggravated, intraocular pressure increased, platelet count increased, tremor. STALEVO dosage: 200 MG 4 IN 1 D ORAL. During the same period patient was treated with ZOLOFT. Patient recovered.

Consumer or non-health professional from FRANCE reported STALEVO problem on July 27, 2006. Female patient, 84 years of age, was diagnosed with parkinson's disease, dysthymic disorder and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: epistaxis, skin haemorrhage. STALEVO dosage: 100/25/200 MG X3 ORAL. During the same period patient was treated with DEROXAT, LAROXYL, LIPANTHYL, SERESTA, DAFALGAN, VASTAREL, NOVONORM. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from FRANCE on July 27, 2006. Male patient, 55 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, condition aggravated, divorced, libido increased, pathological gambling, pollakiuria. STALEVO dosage: unknown. During the same period patient was treated with CELANCE, SINEMET, SIFROL, CLOZAPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported STALEVO problem on July 19, 2006. Male patient, 90 years of age, weighting 220.5 lb, was diagnosed with parkinson's disease, hypertension and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: agitation, anaemia, anorexia, aspiration, asthenia, constipation, insomnia, laryngospasm, pneumonia aspiration. STALEVO dosage: 200 MG, BID. During the same period patient was treated with ENALAPRIL MALEATE, CAPTOPRIL, CILOSTAZOL. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Physician from FRANCE on Apr 11, 2006. Female patient, 69 years of age, weighting 143.3 lb, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, dyspnoea exertional, hypotension. STALEVO dosage: 200/100/25 MG X4/DAY. During the same period patient was treated with REQUIP, MODAFINIL. Patient recovered.

Physician from SWITZERLAND reported STALEVO problem on Apr 28, 2006. Male patient, 78 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: catecholamines urine, hypertension, urine analysis abnormal. STALEVO dosage: 600/350/87.5 MG/D. During the same period patient was treated with EXELON, REQUIP. Patient recovered.

STALEVO problem was reported by a Physician from UNITED STATES on July 25, 2006. Male patient, 68 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: aphasia, fall, grip strength decreased, head injury, vomiting, weight decreased. STALEVO dosage: 450 MG, 3 IN 1 , ORAL. During the same period patient was treated with LITHIUM, WELLBUTRIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported STALEVO problem on Aug 01, 2006. Male patient, 52 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: insomnia, musculoskeletal stiffness. STALEVO dosage: 150 MG (50 MG, 3 IN 1 D) ORAL. During the same period patient was treated with IBUPROFEN, ROPINIROLE, ACETAMINOPHEN. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from BRAZIL on July 28, 2006. Male patient, 90 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: agitation, anaemia, anorexia, asthenia, insomnia, pneumonia aspiration, vocal cord paralysis. STALEVO dosage: 100/25/200MG BID ORAL. During the same period patient was treated with ENALAPRIL MALEATE, CAPTOPRIL, CILOSTAZOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STALEVO problem on Aug 17, 2006. Male patient, 93 years of age, was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: muscle rigidity, nausea. STALEVO dosage: unknown. During the same period patient was treated with COMTAN, SINEMET. Patient recovered.

STALEVO problem was reported by a Physician from TURKEY on July 11, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: agitation, bradycardia, cheyne-stokes respiration, coma, heart rate decreased, intentional overdose, suicide attempt. STALEVO dosage: unknown. During the same period patient was treated with CABASER. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported STALEVO problem on Aug 09, 2006. Female patient, 68 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, asthenia, dizziness, nausea, pancytopenia. STALEVO dosage: 50 MG X 3, ORAL. During the same period patient was treated with LEUKERAN, LYRICA, AMITRIPTYLIN, SIFROL. Patient died.

STALEVO problem was reported by a Consumer or non-health professional from BRAZIL on Aug 04, 2006. Male patient, 90 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: agitation, anaemia, anorexia, asthenia, hereditary disorder, insomnia, laryngospasm, pneumonia aspiration. STALEVO dosage: 100/25/200MG BID ORAL. During the same period patient was treated with ENALAPRIL, CAPTOPRIL, CILOSTAZOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported STALEVO problem on Aug 07, 2006. Male patient, 78 years of age, was diagnosed with blood pressure increased, catecholamines urine increased, parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: catecholamines urine increased, hypertension, phaeochromocytoma. STALEVO dosage: unknown. During the same period patient was treated with EXELON, REQUIP. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from BRAZIL on Aug 11, 2006. Male patient, 84 years of age, was treated with STALEVO. STALEVO dosage: 100 MG. Patient died.

Consumer or non-health professional from FRANCE reported STALEVO problem on Aug 10, 2006. Male patient, 70 years of age, was diagnosed with abnormal behaviour, hallucination, parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, hallucination. STALEVO dosage: 100/25/200MG X 2DF ORAL; SEE IMAGE. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from BRAZIL on Aug 11, 2006. Male patient, 90 years of age, was diagnosed with agitation, anaemia, anorexia, asthenia, constipation, diarrhoea, feeling abnormal, insomnia, jaundice and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: agitation, anaemia, anorexia, asthenia, constipation, diarrhoea, feeling abnormal, insomnia, jaundice. STALEVO dosage: 100/25/200MG ORAL; SEE IMAGE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from NETHERLANDS reported STALEVO problem on Aug 16, 2006. Male patient, 84 years of age, was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: body temperature decreased, loss of consciousness, pneumonia aspiration. STALEVO dosage: unknown. During the same period patient was treated with EXELON, OMNIC, ASCAL. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from AUSTRALIA on Aug 23, 2006. Male patient was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, chest pain, constipation, panic attack, swelling. STALEVO dosage: 150MG X 3 DAILY. Patient recovered.

Consumer or non-health professional from BRAZIL reported STALEVO problem on Aug 24, 2006. Female patient, 73 years of age, weighting 123.5 lb, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: agitation, dysphagia, urinary tract infection, urine colour abnormal, vomiting. STALEVO dosage: unknown. During the same period patient was treated with LEPONEX, REMINYL, REQUIP. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Pharmacist from FRANCE on Aug 11, 2006. Female patient, 70 years of age, weighting 110.2 lb, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: balance disorder, cogwheel rigidity, condition aggravated, gait disturbance. STALEVO dosage: unknown. During the same period patient was treated with MAGNE B, REQUIP, ASPIRIN, PARIET, ACTONEL, ETIOVEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STALEVO problem on Aug 11, 2006. Male patient, 62 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: aggression, asthenia, chest pain, hallucination, visual, headache, hyperhidrosis, movement disorder, musculoskeletal stiffness, pyrexia. STALEVO dosage: 750 MG, 5 IN 1 D, ORAL. During the same period patient was treated with PARCOPA, SINEMET. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from BRAZIL on Aug 16, 2006. Male patient, 84 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: bed rest, condition aggravated, fall, femur fracture, infection, lung disorder, parkinson's disease, respiratory tract infection. STALEVO dosage: 100 MG. Patient was hospitalized. Patient died.

Consumer or non-health professional from FRANCE reported STALEVO problem on Aug 14, 2006. Female patient, 69 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, dyspnoea exertional, hypotension. STALEVO dosage: 100/25/200 MG X 4. During the same period patient was treated with MODAFINIL, REQUIP. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from BRAZIL on Aug 16, 2006. Female patient was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: vasculitis. STALEVO dosage: 100/25/200MG ORAL. Patient recovered.

Consumer or non-health professional from BRAZIL reported STALEVO problem on Aug 23, 2006. Female patient, 87 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abasia, blood calcium decreased, blood potassium decreased, condition aggravated, dysphagia, fluid retention, multi-organ failure, oedema, oral intake reduced. STALEVO dosage: unknown. During the same period patient was treated with REMERON, OMEPRAZOLE, HIDRIUM, ASCORBIC ACID, GINKGO BILOBA. Patient was hospitalized. Patient died.

STALEVO problem was reported by a Consumer or non-health professional from BRAZIL on Aug 17, 2006. Female patient, 87 years of age, was treated with STALEVO. STALEVO dosage: unknown. Patient died.

Consumer or non-health professional from FINLAND reported STALEVO problem on Aug 22, 2006. Female patient, 77 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: allergic respiratory symptom. STALEVO dosage: unknown. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from TURKEY on Aug 16, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: agitation, bradycardia, cheyne-stokes respiration, coma, intentional overdose, suicide attempt. STALEVO dosage: 300 MG (100 MG, 3 IN 1 D) ORAL 1 YEAR AGO. During the same period patient was treated with CABASER. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BELGIUM reported STALEVO problem on Aug 16, 2006. Female patient, 80 years of age, was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abdominal pain, cough, emotional disorder, hallucination, increased upper airway secretion, nausea. STALEVO dosage: 50 MG QD ORAL. During the same period patient was treated with REQUIP, BETASERC, ZESTORETIC, LANOXIN, ZOCOR, AMLOR, ROHYPNOL. Patient recovered.

STALEVO problem was reported by a Pharmacist from UNITED STATES on Sept 01, 2006. Male patient, 83 years of age, was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, back pain. STALEVO dosage: 150 MG 2 TABS 4 X DAILY. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRALIA reported STALEVO problem on Aug 31, 2006. Male patient, 70 years of age, was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: hallucination, incorrect dose administered, paranoia, psychotic disorder. STALEVO dosage: 150MG 5 TIMES A DAY. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from AUSTRALIA on Sept 04, 2006. Male patient was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, agitation, akinesia, chest pain, constipation, panic attack, swelling. STALEVO dosage: unknown. Patient recovered.

Consumer or non-health professional from SWEDEN reported STALEVO problem on Sept 01, 2006. Female patient was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. STALEVO dosage: 100MG, 7-10 TABLETS. Patient recovered.

STALEVO problem was reported by a Pharmacist from UNITED STATES on Aug 17, 2006. Male patient, 93 years of age, was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: muscle rigidity, nausea. STALEVO dosage: 50 MG, QID. During the same period patient was treated with COMTAN, SINEMET. Patient recovered.

Consumer or non-health professional from BRAZIL reported STALEVO problem on Aug 24, 2006. Female patient, 73 years of age, weighting 123.5 lb, was diagnosed with parkinson's disease, dementia and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: agitation, dysphagia, urinary tract infection, urine colour abnormal, vomiting. STALEVO dosage: 150 MG AT 8:00, 100 MG AT 13:00 AND 18:00. During the same period patient was treated with LEPONEX, REMINYL, REQUIP. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Physician from FRANCE on June 05, 2006. Female patient, 78 years of age, was diagnosed with parkinson's disease, dyspepsia and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: colitis, diarrhoea. STALEVO dosage: 600/150/37.5 MG/DAY. During the same period patient was treated with MOTILIUM, MODOPAR, TRIVASTAL, REQUIP, PARIET, PRETERAX. Patient recovered.

Consumer or non-health professional from FRANCE reported STALEVO problem on Sept 18, 2006. Female patient, 85 years of age, was diagnosed with parkinson's disease, hypotension and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: choking, disturbance in attention, dysphagia, dyspnoea, lung disorder, pneumonia aspiration, somnolence. STALEVO dosage: unknown. During the same period patient was treated with GUTRON, ASPIRIN, CACIT D. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Physician from MEXICO on Sept 28, 2006. Female patient, 82 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: dysphagia, gastrostomy, weight decreased. STALEVO dosage: unknown. During the same period patient was treated with BIPERIDEN HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from SWEDEN reported STALEVO problem on Sept 19, 2006. Female patient, 38 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, antepartum haemorrhage, ovarian cyst, treatment noncompliance. STALEVO dosage: unknown. During the same period patient was treated with MADOPARK QUICK MITE. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 20, 2006. Male patient, 93 years of age, was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: muscle rigidity, nausea. STALEVO dosage: 50/12.5/200 MG QID, ORAL. During the same period patient was treated with COMTAN, SINEMET. Patient recovered.

Consumer or non-health professional from MEXICO reported STALEVO problem on Sept 19, 2006. Male patient, 68 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. STALEVO dosage: 25/10/200 MG. During the same period patient was treated with CAPTOPRIL, SIFROL, TELMISARTAN, LEXOTAN, RANITIDINE, AKINETON. Patient died.

STALEVO problem was reported by a Consumer or non-health professional from FRANCE on Sept 18, 2006. Female patient, 78 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal candidiasis. STALEVO dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, OROCAL D, ASPEGIC, DIDRONEL, DEROXAT, PRAZEPAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported STALEVO problem on Sept 18, 2006. Male patient, 77 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: eye pain, ocular hypertension. STALEVO dosage: 600/150/800 MG. During the same period patient was treated with TRIVASTAL, DEPRENYL, MODOPAR, MODOPAR LP. Patient recovered.

STALEVO problem was reported by a Physician from UNITED STATES on Oct 03, 2006. Female patient, 81 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: dizziness, hypotension. STALEVO dosage: unknown. During the same period patient was treated with DETROL. Patient recovered.

Consumer or non-health professional from DENMARK reported STALEVO problem on Sept 26, 2006. Female patient, 82 years of age, was diagnosed with parkinsonism and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: constipation, diarrhoea, hypokalaemia, hyponatraemia. STALEVO dosage: unknown. During the same period patient was treated with ALOPAM, VAGIFEM, AMANTADINE, PINEX, NOBLIGAN R. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from FRANCE on Sept 26, 2006. Male patient was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis. STALEVO dosage: 750/187,5/1000 MG ORAL. During the same period patient was treated with IPERTEN, SINEMET. Patient recovered.

Consumer or non-health professional from ROMANIA reported STALEVO problem on Sept 25, 2006. Female patient, 64 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, angina pectoris, cholecystitis, coronary artery disease, face oedema, flatulence, hepatic steatosis, hydronephrosis, nephrolithiasis. STALEVO dosage: 100/25/200MG X 5 ORAL. During the same period patient was treated with MIRAPEXIN. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from FRANCE on Sept 30, 2006. Female patient, 85 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, dysphagia, dyspnoea, pneumonia aspiration, somnolence. STALEVO dosage: unknown. During the same period patient was treated with GUTRON, ASPIRIN, CACIT D. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported STALEVO problem on June 05, 2006. Female patient, 78 years of age, was diagnosed with parkinson's disease, dyspepsia and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: colitis, diarrhoea. STALEVO dosage: 600/150/37.5 MG/DAY. During the same period patient was treated with MOTILIUM, MODOPAR, TRIVASTAL, REQUIP, PARIET, PRETERAX. Patient recovered.

STALEVO problem was reported by a Physician from FRANCE on Oct 24, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. STALEVO dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ARGENTINA reported STALEVO problem on Oct 24, 2006. Female patient, 58 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: fall, hip fracture, surgery. STALEVO dosage: 50 MG, BID. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Physician from UNITED STATES on Nov 01, 2006. Male patient, 62 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: squamous cell carcinoma. STALEVO dosage: 50 MG, TID. During the same period patient was treated with MIRAPEX, AZILECT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported STALEVO problem on Oct 02, 2006. Female patient, 56 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: convulsion. STALEVO dosage: unknown. During the same period patient was treated with AMITRIPTYLINE, LANSOPRAZOLE, SINEMET. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from SWEDEN on Oct 25, 2006. Female patient, 38 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, ovarian cyst. STALEVO dosage: 100MG, 7 TABLETS ORAL. During the same period patient was treated with MADOPARK QUICK MITE. Patient recovered.

Consumer or non-health professional from FRANCE reported STALEVO problem on Oct 25, 2006. Female patient, 78 years of age, was diagnosed with parkinson's disease, dyspepsia and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: colitis. STALEVO dosage: 150/37,5/600 MG ORAL. During the same period patient was treated with MOTILIUM, MODOPAR, TRIVASTAL, REQUIP, PARIET, PRETERAX. Patient recovered.

STALEVO problem was reported by a Health Professional from MEXICO on Oct 26, 2006. Male patient, 57 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: condition aggravated, parkinson's disease. STALEVO dosage: 50/12,5/200 MG X 7 ORAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported STALEVO problem on Nov 01, 2006. Male patient, 67 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: skin cancer, skin neoplasm excision. STALEVO dosage: 50 MG, TID. During the same period patient was treated with MIRAPEX, AZILECT, GLUCOVANCE, GLUCOTROL. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from FRANCE on Nov 10, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease, nasal sinus cancer, stent placement and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: anxiety, disorientation, memory impairment. STALEVO dosage: 600/400/100 MG/DAY. During the same period patient was treated with XELODA, CORVASAL, LEPONEX, CITALOPRAM HYDROBROMIDE, EQUANIL. Patient recovered.

Pharmacist from UNITED STATES reported STALEVO problem on Nov 27, 2006. Male patient, 86 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, nausea, vomiting. STALEVO dosage: 50 MG TID PO. During the same period patient was treated with ASPIRIN, NEURONTIN, PAXIL, LASIX, ELAVIL, COREG. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from ARGENTINA on Nov 04, 2006. Female patient was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: fall, hip fracture. STALEVO dosage: 50MG BID. Patient was hospitalized. Patient recovered.

Health Professional from FINLAND reported STALEVO problem on Nov 15, 2006. Female patient, 66 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dyskinesia, dystonia, facial spasm, fall, laryngeal oedema, lip disorder, muscle spasms, muscle tightness. STALEVO dosage: 150 MG, 4 IN 1 D ; 150 MG, 5 IN 1 D ; 900MG (150 MG, 6 IN 1 D) ; 750 MG (150 MG, 5 IN 1 D). During the same period patient was treated with OXEPAM, ASASANTIN RETARD, ESCITALOPRAM OXALATE, LESCOL. Patient was hospitalized. Patient recovered.

STALEVO problem was reported by a Consumer or non-health professional from ROMANIA on Nov 07, 2006. Male patient, 63 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, bronchopneumonia, hypernatraemia, respiratory failure, rhabdomyolysis, urinary tract infection pseudomonal. STALEVO dosage: 600 MG ORAL. During the same period patient was treated with AMPICILINA, GENTAMICIN, CIPROFLOXACIN, ZINACEF, SULPERAZONE, ALGOCALMIN, ACETAMINOPHEN, ROPINIROLE. Patient died.

Consumer or non-health professional from GERMANY reported STALEVO problem on Nov 08, 2006. Female patient, 76 years of age, was diagnosed with parkinson's disease and was treated with STALEVO. After drug was administered, patient experienced the following problems/side effects: atrioventricular block first degree, loss of consciousness, syncope. STALEVO dosage: unknown. During the same period patient was treated with MADOPAR LT, SIFROL, SEROQUEL. Patient was hospitalized. Patient recovered.

Showing 1-75 of 198 Next >

Ask Our Patient Community about STALEVO

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole